Skip to Main Content

Try STAT+ TODAY

pharmaceuticlas

All Coverage

First Opinion John LaMattina

Big Pharma could boost its reputation with a solid response to Covid-19

First Opinion Christine Simmon

Games and greed delay the market entry of money-saving biosimilars

First Opinion David Mitchell

Allergan invokes the victim defense to protect a brand-name drug from a generic challenge